RealFeedApp The first reprogramming trial shows initial results
Life Biosciences published preliminary data from its first clinical trial on cellular reprogramming. The study involved creating chimeric antigen receptor natural killer cells directly in the body using messenger RNA.
- Field
- ageing and longevity
- What they did
- Researchers from Life Biosciences presented preliminary results from the first clinical trial involving cell reprogramming aimed at extending lifespan.
- Why it matters
- This step allows testing the effectiveness of methods designed to suppress aging and age-related diseases.
#reprogramming#clinical trial#natural killer cells#mrna#aging
